HR 8333 118th Congress House Health Asia China Congressional oversight Diplomacy, foreign officials, Americans abroad Foreign and international corporations Government employee pay, benefits, personnel management Government information and archives Government lending and loan guarantees Government studies and investigations Health technology, devices, supplies Public contracts and procurement

BIOSECURE Act

Introduced: May 14, 2024 See on congress.gov

Everywhere this bill has been 12 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 10, 2024

Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Sep 9, 2024

Mr. Comer moved to suspend the rules and pass the bill, as amended.

Sep 9, 2024

Motion to reconsider laid on the table Agreed to without objection.

Sep 9, 2024

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)

Sep 9, 2024

Considered as unfinished business. (consideration: CR H5081-5082)

Sep 9, 2024

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Sep 9, 2024

Considered under suspension of the rules. (consideration: CR H5051-5058)

Sep 9, 2024

DEBATE - The House proceeded with forty minutes of debate on H.R. 8333.

May 15, 2024

Committee Consideration and Mark-up Session Held

May 15, 2024

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.

May 10, 2024

Referred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 10, 2024

Introduced in House

Votes taken on this bill 1

Date	Chamber	What was voted on	Result	Yes–No
Sep 9, 2024	House · vote #402	On Motion to Suspend the Rules and Pass, as Amended	Passed	306–81	See who voted →

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

BIOSECURE Act

This bill prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary.

Specifically, federal agencies and recipients of federal funds (e.g., grantees) may not procure or use any biotechnology equipment or service that is from a biotechnology company of concern and may not contract with any entities that do so. A biotechnology company of concern is an entity that is under the control of a foreign adversary and that poses a risk to national security based on its research or multiomic data collection (e.g., collection of genomic information).

The Office of Management and Budget (OMB) must, in coordination with the Department of Defense (DOD) and other specified agencies, develop a list of prohibited companies; the list must include five particular companies, as specified in the bill. OMB and DOD may approve waivers of these restrictions on an as-needed basis, which are valid for up to one year and may be extended once for an additional 180 days.

In addition, the Office of the Director of National Intelligence must report on the national security risks posed by (1) multiomic data collection by foreign adversaries in connection with biotechnology equipment or services, and (2) biotechnology companies that have such data.

What's happening now September 10, 2024

Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Related & companion bills 1

Bill text 3 versions

Engrossed in House Formatted Text PDF Formatted XML
Introduced in House Formatted Text PDF Formatted XML
Referred in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 3

Intelligence (Permanent Select) Committee
House of Representatives
Oversight and Government Reform Committee
House of Representatives
Homeland Security and Governmental Affairs Committee
Senate

Lobbying activity 2

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

EXECUTIVE STRATEGIES, LTD. CO.
for SENTINEL API GROUP, INC. · Florida · 3rd Quarter (July 1 - Sep 30) 2025
AKIN GUMP STRAUSS HAUER & FELD
for FUJIFILM HOLDINGS AMERICA CORPORATION · New York · 1st Quarter (Jan 1 - Mar 31) 2025

Cosponsors 13